Well it looks like this about to explode. July 3 2024 it was .485, more than doubled.
Very strong pre market today:
Keep an eye on CTXR----]Citius Pharmaceuticals
Citius’ first FDA decision date is approaching and expected to be approved this Friday for a merger of their subsidery as a tax free spin off.— and its CEO has millions on the line
Citius Pharmaceuticals CEO Leonard Mazur has personally invested $22.5 million into the company, which is fast approaching a potential turning point.With its PDUFA date slated for Aug. 13, Citius Pharmaceuticals is on that path with Lymphir, an immunotherapy for a rare blood cancer.